Skip to search.
 FTSE 100 Up 0.46%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
1.68 Down 0.10(5.62%) 22 Jul 21:00
|After Hours: : 1.68 0.00 (0.00%) 23 Jul 00:32
Prev Close:1.78
Open:1.78
Bid:1.53 x 500
Ask:1.68 x 300
1y Target Est:3.75
Beta:1.40139
Earnings Date:3 Aug - 8 Aug (Est.)
Day's Range:1.68 - 1.79
52wk Range:1.30 - 4.17
Volume:3,396,243
Avg Vol (3m):1,822,300
Market Cap:408.32m
P/E (ttm):N/A
EPS (ttm):-0.44
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNADown 5.62%408.32m
OREX 0.00%51.09m
GSKUp 0.64%106.58b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.34
Quarterly EPS Est (Jun-16) :-0.10
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.26

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors to address unmet medical needs in the United States and South Korea. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback